Musculoskeletal Transplant Foundation, Inc. — commonly shortened to MTF and rebranded MTF Biologics in October 2017 — is a nonprofit organization headquartered at 125 May Street, Edison, New Jersey. It was incorporated on January 30, 1987, as a District of Columbia nonprofit membership organization and operates as a 501(c)(3) charity; it has no public ticker and is not a subsidiary of another company. Its most recent IRS Form 990 (FY2024) reports roughly $509 million in total revenue and about $323 million in assets, and lists more than 1,300 employees, though third-party business databases report lower headcount figures (in the hundreds).
Operations. MTF describes itself as the world's largest tissue bank. It recovers donated human tissue through a network of organ procurement and tissue recovery partners, then processes and distributes allograft tissue — bone, dermal/skin, tendon, ligament, cartilage, birth (amniotic) tissue and heart valves — to hospitals, surgery centers and surgeons. End markets include orthopedics, spine, plastic and reconstructive surgery, burn care and wound care. It also runs two named subsidiaries: Statline, which manages donor referral operations, and IIAM (International Institute for the Advancement of Medicine), which places non-transplantable organs and tissue for research. Funding comes from tissue service fees rather than donations, and the organization funds external research grants.
Litigation posture. The structured data show MTF with one tracked case and zero appearances as a plaintiff — the signature of an operating company being sued rather than a patent assertion entity. It does not assert patents offensively in this database.
Notable case. LifeNet, Inc. v. Musculoskeletal Transplant Foundation, Inc., filed June 5, 2006 in the U.S. District Court for the Eastern District of Virginia, Richmond Division. LifeNet (now LifeNet Health), a Virginia-based tissue bank and direct competitor, alleged infringement of patents covering bone-cleaning and bone-demineralization processes. Reports from Virginia Lawyers Weekly and case records indicate a jury found LifeNet's claims valid and infringed, with post-trial motions for judgment as a matter of law, new trial and remittitur denied in April 2008. Related interlocutory disputes included MTF's advice-of-counsel privilege waiver and an unsuccessful MTF motion to disqualify LifeNet's counsel. The Richmond venue reflects the parties' home forum rather than a plaintiff-friendly NPE district such as the Eastern District of Texas.